Innovative Leasing Program for MiniOmni Osteoporosis Screening
Twin Cities, MN— August 25th, 2023 —Biomedix, a market-leading medical technology and innovation company, and BeamMed, a developer, manufacturer and marketer of best-in-class bone density assessment solutions, announced a new strategic partnership to assist value-based care organizations close OMW and OSW HEDIS gaps.
“We are pleased to announce this partnership that expands access to our enabling technology for existing and new customers,” said Tal Maron, CEO of BeamMed. “By connecting MiniOmni devices to a cloud-services platform, our clients can track productivity and performance in real-time. This can be done across multiple users, locations, and devices, facilitating analysis to coordinate and deliver better care.”
“As part of our enhanced partnership with BeamMed, we are thrilled to offer a broader spectrum of business terms to the market,” said John Romans, CEO at Biomedix. “Now, the BeamMed MiniOmni device is available through a rental or operating lease program, easing the capital budgeting requirements for service providers and other entities tasked with screening appropriate member populations for osteoporosis with a quick and accurate device that does not compromise accuracy.”
About Biomedix
Biomedix is a provider of point-of-care diagnostic solutions for delivering value-based care. Biomedix Xchange is a population health solution that centralizes data for analyzing population health across multiple chronic conditions. For more information, visit Biomedix.com.
About BeamMed
BeamMed develops, manufactures, and markets bone density assessment solutions. In particular, BeamMed leads the market with advanced ultrasound technology and portable bone density devices that enable physicians to provide early assessment, diagnosis, and monitoring of osteoporosis and to assess bone development. BeamMed’s devices leverage the patented Omnipath™ axial transmission technology that effectively screens for osteoporosis and improves HEDIS measures, allowing reaching 5-stars rating for HEDIS OMW and OSW.
